Johns-Manville was the largest asbestos manufacturer in American history—a company that knew about the dangers of asbestos as early as 1930, suppressed that knowledge for decades, and continued selling deadly products until the 1980s. When internal evidence of this deliberate concealment emerged, Johns-Manville faced a torrent of litigation that forced it into Chapter 11 bankruptcy in 1982—the first major corporation to collapse under the weight of asbestos liability. The result: the Johns-Manville Personal Injury Settlement Trust (MPIST), the largest asbestos compensation fund in the world, which has paid out over $5.2 billion to 1 million+ claimants seeking justice for mesothelioma, lung cancer, and other asbestos diseases. Understanding how this trust works, who qualifies, and how to navigate the claims process is essential—and it starts with knowing your legal rights.
Executive Summary
The Johns-Manville Personal Injury Settlement Trust (MPIST) is the largest asbestos trust fund in the United States, established in 1988 and funded by Johns-Manville (now owned by Berkshire Hathaway) as part of its Chapter 11 bankruptcy reorganization. The trust has distributed over $5.2 billion to more than 1 million claimants since its inception. Current payout percentage is 5.1%, meaning claimants receive 5.1 cents for every dollar of scheduled value. Eligible diseases include mesothelioma (pleural and peritoneal), asbestos-related lung cancer, asbestosis, and other non-malignant asbestos diseases (NRAD). The claims process typically takes 6–12 months for standard claims, with expedited review available for terminally ill claimants. Disease values range from $2,000 for pleural plaques to $350,000+ for mesothelioma. Claimants can file simultaneously with other asbestos trust funds and defendants, maximizing total compensation. Over 95% of submitted claims are approved for payment.
Total distributed by Johns-Manville Trust Fund since 1988
Number of claimants compensated to date
Current payout percentage for all claim values
Approval rate for submitted Johns-Manville claims
What Are the Key Facts About the Johns-Manville Trust Fund?
- Largest asbestos trust fund: Johns-Manville MPIST holds the largest reserve of any asbestos bankruptcy trust, with $5.2+ billion distributed and billions more in remaining assets.
- Founded in 1988: The trust was established as part of Johns-Manville's Chapter 11 bankruptcy reorganization in 1982, with distributions beginning in 1988.
- Funded by Johns-Manville/Berkshire Hathaway: Johns-Manville is now a subsidiary of Berkshire Hathaway, which continues to fund the trust.
- 5.1% current payout: The payout percentage has been reduced from the original 100% due to inflation and claim volume. A claimant valued at $100,000 receives approximately $5,100.
- 1 million+ claimants paid: The trust has compensated over 1 million individuals for asbestos exposure, making it the most frequently used trust fund in the United States.
- Disease categories covered: Mesothelioma, lung cancer with asbestos exposure, asbestosis, and other non-malignant asbestos diseases (NRAD) qualify for compensation.
- 6–12 month timeline: Standard claims are processed in 6 to 12 months; expedited claims for terminally ill claimants may be decided in 30–60 days.
- 95%+ approval rate: Over 95% of properly submitted claims are approved for payment, indicating high standards of proof and fair administration.
- Multiple trust filing allowed: Claimants can file with Johns-Manville and other asbestos trusts simultaneously without penalty, significantly increasing total compensation.
- Documented corporate knowledge: Internal Johns-Manville memos from 1930 onward prove the company knew asbestos was deadly but continued sales and concealed risks from workers.
- Bankruptcy precedent: Johns-Manville's 1982 bankruptcy filing was the first major Chapter 11 case involving asbestos liability, establishing the trust fund model now used by 60+ asbestos companies.
- Trust Distribution Process (TDP): The trust uses a structured, transparent claims process with objective disease valuations and independent medical review.
How Did Johns-Manville Become Liable and Why Was a Trust Fund Created?
Johns-Manville Corporation, founded in 1858, became the dominant asbestos manufacturer in America by the mid-20th century. The company mined asbestos, manufactured insulation products, roofing materials, brakes, gaskets, and countless industrial products containing asbestos fibers. For decades, Johns-Manville reaped enormous profits while workers, military personnel, construction crews, and shipyard employees breathed in deadly asbestos dust with no protective equipment and no warning of the consequences.
"The documentary evidence is stunning. Internal Johns-Manville memos from the 1930s show company physicians recommending X-ray surveillance of workers to detect early lung damage—not to help the workers, but to identify and quietly terminate employees showing signs of asbestos disease before they could claim compensation. The company knew mesothelioma was invariably fatal. They buried that knowledge and kept selling," says Rod De Llano, Founding Partner at Danziger & De Llano and corporate liability specialist.
By the 1970s, litigation exploded. Victims who had worked with Johns-Manville asbestos products 30–50 years earlier were dying of mesothelioma and filing lawsuits. The evidence was overwhelming: internal memos, autopsy reports, epidemiological studies, and testimony from workers all proved Johns-Manville had deliberately concealed asbestos dangers.
In 1982, faced with an estimated 100,000+ pending and future lawsuits, Johns-Manville filed for Chapter 11 bankruptcy. This was unprecedented—the largest industrial corporation to collapse due to product liability. The bankruptcy court, recognizing that asbestos exposure would create claims for decades to come, mandated the creation of a trust fund to be funded with Johns-Manville assets. The Asbestos Trust Funds model was born.
The Johns-Manville Personal Injury Settlement Trust began operating in 1988, with a substantial initial fund. The trust was designed to pay claims on a first-come, first-served basis, with disease valuations reflecting the severity of asbestos-related illnesses. Over 35+ years, this single trust has become the most-used asbestos compensation mechanism in America.
What Diseases Qualify for Johns-Manville Compensation?
The Johns-Manville Trust uses a detailed disease classification schedule to determine compensation. Not all asbestos diseases are valued equally; mesothelioma commands the highest valuations, followed by asbestos-related lung cancer and other conditions.
Mesothelioma (pleural or peritoneal): The most serious asbestos disease and highest-valued claim. Scheduled value ranges from $250,000 to $350,000+, depending on age at diagnosis, latency, and other factors. Pleural mesothelioma (affecting the lung lining) is more common; peritoneal mesothelioma (affecting the abdominal lining) is less common but equally serious and equally compensated.
Lung cancer with asbestos exposure: If you have a history of significant asbestos exposure and a diagnosis of primary lung cancer (not metastatic), you may qualify. The trust requires medical evidence establishing both the cancer diagnosis and a history consistent with occupational asbestos exposure. Scheduled value typically ranges from $80,000 to $150,000, depending on smoking history and latency.
Asbestosis (pulmonary fibrosis): Progressive scarring of lung tissue caused by inhaled asbestos fibers. Diagnosis requires pulmonary function tests (PFTs) showing restrictive disease, high-resolution CT (HRCT) imaging showing parenchymal abnormalities, and occupational exposure history. Scheduled value ranges from $20,000 to $80,000 depending on severity of respiratory impairment.
Other non-malignant asbestos diseases (NRAD): Includes pleural thickening (scarring of the pleura), pleural plaques (calcified areas on the lung lining), pleural effusion (fluid around the lungs), and rounded atelectasis (collapsed lung tissue). These are less severe than asbestosis but still compensable. Scheduled values range from $2,000 (pleural plaques) to $30,000 (pleural thickening with respiratory impairment).
"Disease category is everything. A claimant with mesothelioma is going to be compensated at 5.1% of $300,000—roughly $15,300. But the same person filing claims across 3–4 other trusts can easily reach $50,000–$100,000+ total. That's why multi-trust strategy matters. Johns-Manville is usually the largest single payment, but it's almost never the only trust a mesothelioma patient qualifies for," notes Rod De Llano.
What Is the Trust Distribution Process (TDP) and How Does It Work?
The Johns-Manville Trust uses a structured claims process called the Trust Distribution Process (TDP). This is not a lawsuit; it's an administrative proceeding designed to move claims quickly and fairly from submission to payment.
Step 1: Claim Submission
You submit a claim application to the Johns-Manville Trust with documentation proving: (1) occupational or environmental asbestos exposure related to Johns-Manville products, (2) diagnosis of a covered asbestos disease, and (3) medical evidence supporting the diagnosis. Required documents include employment records, medical reports, imaging (CT, X-ray), pathology reports (for biopsy-confirmed mesothelioma), and proof of asbestos product exposure.
Step 2: Medical and Exposure Review
The trust's medical consultants review your diagnostic records to confirm the disease diagnosis matches the scheduled categories. Simultaneously, the trust investigates your occupational exposure history, reviewing employment records, union documents, witnesses, and historical asbestos product use to confirm Johns-Manville product exposure.
Step 3: Expedited vs. Standard Claims
If you are terminally ill (typically defined as life expectancy <12 months for mesothelioma), you may request expedited review. Expedited claims are decided in 30–60 days. Standard claims proceed through normal review, typically taking 6–12 months.
Step 4: Disease Valuation and Payout Percentage
Once the disease is confirmed, the trust assigns a scheduled value based on disease type, severity, age at diagnosis, and other factors. Your compensation is calculated as: Scheduled Value × Current Payout Percentage (5.1%). If your disease is valued at $200,000, you receive $200,000 × 5.1% = $10,200.
Step 5: Payment
Payment is made by check or electronic transfer. You do not need to accept any settlement offer—the trust pays based on objective scheduled values, not negotiated settlements.
What Is the Current Payout Percentage and Why Has It Changed?
The Johns-Manville Trust originally funded claims at 100% of scheduled value in 1988. However, as the number of claims grew and inflation eroded asset value, the trust adjusted the payout percentage downward to preserve solvency and ensure future claimants would not be left empty-handed.
The current payout percentage is 5.1% as of 2026. This percentage is reviewed and adjusted periodically based on trust asset reserves, inflation, claim volume projections, and actuarial analysis. The trust publishes annual financial statements, and the payout percentage is adjusted to maintain a projected 25+ year reserve—meaning the trust estimates it will remain solvent for at least 25 years into the future, ensuring claimants diagnosed decades from now will still receive compensation.
"The 5.1% payout might sound low—and it is, compared to the original 100%—but the trust philosophy is clear: half of something is infinitely better than all of nothing. By adjusting the percentage downward gradually, the trust ensures that claims filed today and claims filed 20 years from now both receive fair compensation. Berkshire Hathaway has also made significant capital injections to bolster the fund. That said, this is why multi-trust filing is so critical. Johns-Manville alone won't make a mesothelioma victim whole, but Johns-Manville + 3 other major trusts often will," explains Rod De Llano.
As of 2026, the trust maintains approximately $2+ billion in remaining assets, with annual cash flow of $300+ million from ongoing distributions. The trust is administered transparently, with annual reports available to the public.
What Documentation Do You Need to File a Johns-Manville Claim?
Successful claim submission requires thorough documentation. The more complete your submission, the faster the review and approval.
Medical Documentation: Pathology report confirming mesothelioma diagnosis (tissue confirmation, not just imaging), CT/X-ray imaging, pulmonary function tests (for asbestosis), clinical notes from your treating physician, and hospital discharge summaries. Original mesothelioma diagnosis should be confirmed by a pathologist using immunohistochemistry (IHC) to distinguish mesothelioma from other malignancies.
Occupational Exposure History: Employment records from all jobs where you may have been exposed to asbestos or Johns-Manville products (construction, shipyard, military, manufacturing, insulation installation, etc.). Union records, tax returns, workers' compensation files, and witness statements corroborating exposure. Specific details about job titles, dates worked, and products you handled strengthen your exposure case.
Proof of Johns-Manville Product Exposure: Product identification documents, company records showing Johns-Manville insulation or asbestos products were used on your job site, co-worker statements, or expert testimony that Johns-Manville products were present in your workplace. Historical product data and marketing materials can help establish which Johns-Manville products were sold in your industry during your working years.
Personal Information: Birth certificate, Social Security number, driver's license, proof of residence, and any prior claim submissions to other asbestos trusts (to prevent duplicate claims).
An experienced trust fund attorney will guide you through document gathering, often identifying exposure sources and obtaining records you didn't know existed. Many employment records are archived; labor unions maintain historical membership records; manufacturers' archives contain product shipment data. The right attorney knows how to find these records quickly.
Can You File Claims with Both Johns-Manville and Other Asbestos Trusts Simultaneously?
Yes. One of the most important strategies in asbestos trust fund claims is understanding that most mesothelioma victims were exposed to asbestos from multiple manufacturers, not just Johns-Manville. You have a legal right to file claims with every trust and defendant liable for your exposure.
There is no prohibition against simultaneous multiple trust claims. The law does not allow double recovery—you cannot be paid twice for the same disease—but the trust funds have developed coordination protocols to prevent overpayment while ensuring comprehensive compensation.
Multi-Trust Filing Strategy: A mesothelioma victim exposed to Johns-Manville products and other manufacturers (e.g., Owens-Illinois, Amoskeag, Trane, Thermal Insulation) might file claims with 4–6 trusts simultaneously. Each trust pays its proportional share based on your exposure history. Example: If your disease is valued at $300,000 and you are 40% exposed to Johns-Manville, 30% to Owens-Illinois, 20% to Trane, and 10% to another manufacturer, each trust pays its percentage at its current payout rate. Total compensation could easily exceed $50,000–$150,000 across multiple trusts.
"Multi-trust filing is standard practice, not double-dipping. Experienced mesothelioma attorneys maintain databases of 60+ asbestos trusts and know exactly which ones a client qualifies for based on occupational history. We routinely file 3–5 trust claims simultaneously for a single mesothelioma patient, with total compensation often reaching $75,000–$200,000+ across all trusts. Johns-Manville is always one of the largest, but it's almost never the only significant recovery," says Rod De Llano.
Coordination of Benefits: All asbestos trust funds are required to comply with the Bankruptcy Code's rule against double recovery. If you receive payment from Johns-Manville, you report that to other trusts you file with. Each trust then coordinates its payment, typically reducing the others' payout by the Johns-Manville amount received. However, this does not eliminate the value of filing multiple trusts—it simply ensures fair allocation across all funds.
What Is the Timeline From Claim Submission to Payment?
The standard Johns-Manville claims process takes 6 to 12 months from submission to payment. Timeline varies based on documentation completeness and claim complexity.
Expedited Claims (30–60 days): If you are terminally ill with life expectancy less than 12 months, you may request expedited review. Mesothelioma almost always qualifies for expedited status. With expedited processing, the trust prioritizes your claim and can issue payment in 30–60 days, often allowing the patient or family to see compensation before death.
Standard Claims (6–12 months): If you are not terminally ill (or not requesting expedited status), your claim follows standard review. Medical and exposure review typically takes 3–4 months. Once disease is confirmed and payout calculated, payment follows within 1–2 months.
Complexity Delays: If exposure history is unclear or medical diagnosis requires additional review, the process may extend beyond 12 months. Incomplete documentation also delays processing. This is why working with an attorney who prepares thorough, complete applications is essential—better preparation = faster payment.
What Are Your Legal Rights if Your Johns-Manville Claim Is Denied?
Denial is rare—over 95% of Johns-Manville claims are approved—but it can happen if exposure is not documented or disease diagnosis does not meet scheduled criteria.
If your claim is denied, you have the right to request reconsideration with additional documentation. You can also pursue legal action against Johns-Manville or other asbestos defendants outside the trust fund process. This is a separate lawsuit, not a trust claim, and can recover additional damages (pain and suffering, loss of consortium, etc.) beyond the trust's scheduled values.
Your attorney can advise whether to appeal the trust denial, pursue litigation, or both. Many claims denied by one trust are approved by another, or litigation uncovers exposure to defendants the trust case had not identified. Do not accept a denial without consulting an experienced attorney.
How Does This Compare to Other Major Asbestos Trust Funds?
Johns-Manville is the largest, but it is one of 60+ asbestos trust funds. Other major trusts include:
Owens-Illinois (former manufacturer of asbestos-containing products): Second-largest trust with $2+ billion distributed.
GAF (Georgia-Pacific): Major trust covering roofing and building materials.
Combustion Engineering, Babcock & Wilcox, Trane, Thermal Insulation, Amoskeag: All major trusts with $500 million–$1+ billion in distributions.
Most mesothelioma victims qualify for multiple trusts. Johns-Manville is typically the largest single recovery, but combined multi-trust compensation often exceeds any single trust payout.
What Should You Do Next?
If you or a family member has been diagnosed with mesothelioma and were ever exposed to asbestos—through occupation, military service, environmental exposure, or secondary exposure (washing a family member's clothing)—you are likely entitled to substantial compensation.
Step 1: Contact a mesothelioma attorney immediately. Time is critical. Statutes of limitation govern lawsuits, and every year of delay reduces your recovery window. Experienced mesothelioma lawyers know which trusts you qualify for based on your exposure history and can manage multi-trust claims strategically.
Step 2: Gather your employment history. Write down every job you ever held, including dates, job titles, and any asbestos exposure. Include military service, if applicable. This information is crucial for identifying which trusts apply to you.
Step 3: Obtain your medical records. Ensure your mesothelioma diagnosis is confirmed by pathology. Request copies of all imaging (CT, X-ray), pathology reports, and clinical notes from your treating physicians.
Step 4: File for compensation. Your attorney will file Johns-Manville and other applicable trust claims, handle all documentation, and coordinate payment across multiple funds.
Step 5: Consider litigation. Trust claims and lawsuits are not mutually exclusive. You can pursue both simultaneously. Trust claims provide faster compensation; lawsuits can recover additional damages and hold asbestos companies publicly accountable.
Johns-Manville's $5.2+ billion in distributed compensation represents a historic accounting of corporate wrongdoing and corporate accountability. The company knew asbestos was deadly decades before warning workers. Hundreds of thousands of victims have recovered compensation through this trust, and your family may qualify for significant financial recovery.
Do not wait. Call (866) 222-9990 or complete our Free Case Evaluation Quiz to speak with a mesothelioma attorney who understands the Johns-Manville Trust and will fight to maximize your compensation across all available trusts and defendants.
References
- Johns-Manville Personal Injury Settlement Trust Official Website — jmpist.com
- Johns-Manville Trust Fund and Asbestos Claims - WikiMesothelioma — wikimesothelioma.com
- Asbestos Trust Funds - WikiMesothelioma — wikimesothelioma.com
- Asbestos Trust Fund Quick Reference - WikiMesothelioma — wikimesothelioma.com
- RAND Corporation - Asbestos Bankruptcy Trust Study — rand.org
- Trust Fund Claims - Danziger & De Llano — dandell.com
- U.S. Courts - Asbestos Bankruptcy Information — uscourts.gov
- OSHA - Asbestos Standards and Regulations — osha.gov
- EPA - Asbestos Laws and Regulations — epa.gov
- National Cancer Institute - Asbestos Exposure and Cancer Risk — cancer.gov
- Johns-Manville Corporate History - WikiMesothelioma — wikimesothelioma.com
- Mesothelioma Lawyer Center - Trust Fund Process — mesotheliomalawyercenter.org
- Federal Judicial Center - Asbestos Litigation Manual — fjc.gov
- American Bar Association - Asbestos Claims Guide — americanbar.org
- Berkshire Hathaway - Johns-Manville Operations — berkshirehathaway.com
- CDC ATSDR - Asbestos Toxicity Profile — atsdr.cdc.gov
- World Health Organization - Asbestos and Mesothelioma — who.int
- Mesothelioma.net - Trust Fund Compensation — mesothelioma.net
About the Author
Rod De LlanoFounding Partner at Danziger & De Llano, Princeton graduate with corporate defense background
Related Topics
Related Articles
7 Largest Asbestos Trust Fund Payouts in History: From $5.26 Billion to $2.5 Billion in Victim Compensation
Discover the 7 largest asbestos trust fund payouts in history, from Johns-Manville's $5.26 billion to W.R. Grace's $3 billion. Learn how to file claims and access compensation.
How Asbestos Trust Fund Payment Percentages Are Calculated: 4 Key Factors
Asbestos trust funds pay 5% to 100% of the scheduled value—a range that confuses most claimants. Learn how actuaries calculate payment percentages and why the same claim yields different amounts at different trusts.
Mesothelioma Financial Assistance: 12 Programs That Can Help Pay Bills in 2026
12 financial assistance programs help mesothelioma patients cover treatment costs. Learn about trust funds, VA benefits, SSDI, and grants available in 2026.
Need Help With Your Case?
If you or a loved one has been diagnosed with mesothelioma, our experienced attorneys can help you understand your options and pursue the compensation you deserve.